Thore Hettmann,Daniel J. Freeman,Robert Radinsky,Mike Rothe
申请号：
US15000005
公开号：
US20160222126A1
申请日:
2016.01.18
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Described herein are materials and methods for treating subjects having a HER-3 associated disease, by administering a first agent that binds to HER-3, in combination with a second agent that binds and/or inhibits another member of the HER family. The first and the second agent may be a biologic, such as an antigen-binding protein, or a small molecular tyrosine kinase inhibitor, for example.
